| Intrinsic Valuation of: CRISIL | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 115 | Market Cap | ₹303B | |||||
| 2021 | - | - (-) | P/E Ratio | 36 | Total Asset | ₹46B | |||||
| 2022 | ₹4B | - (-) | Net Income | ₹8B | Total Debt | ₹0 | |||||
| 2023 | ₹7B | 72.8% (52.4%) | EBITDA | ₹12B | Total Liab | ₹16B | |||||
| 2024 | ₹6B | -17.5% (-20.5%) | Opr Margin | 26.23 | Debt/Equity | - | |||||
| 2025 | ₹7B | 15.3% (3.0%) | PreTax Margin | 25.62 | BV/Share | 276 | |||||
| 5Y Average FCF | ₹6B | 15.0% (11.6%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.00% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (15.0%) | ||||||||||
| 2026 | ₹8B | MBG Intrinsic Value | ₹1,025 | ||||||||
| 2027 | ₹9B | ||||||||||
| 2028 | ₹9B | ||||||||||
| 2029 | ₹10B | ||||||||||
| 2030 | ₹11B | ||||||||||
| 2031 | ₹11B | ||||||||||
| Terminal Value | ₹246B | Net Worth/Share | ₹415 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹208B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹3B | ₹2,890 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹0 | WACC | 6.5% | 2,715 | 2,953 | 3,250 | 3,632 | 4,141 | |||
| Equity Value | ₹211B | 7.1% | 2,414 | 2,595 | 2,815 | 3,089 | 3,437 | ||||
| Shares Outstanding | 73,130,017 | 7.8% | 2,170 | 2,311 | 2,479 | 2,681 | 2,932 | ||||
| 8.4% | 1,970 | 2,082 | 2,214 | 2,369 | 2,556 | ||||||
| DCF Intrinsic Value | ₹2,890 | 9.0% | 1,807 | 1,898 | 2,003 | 2,126 | 2,270 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||